Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

3.920 USD +0.170 (+4.53%)
Official Closing Price Updated: 7:33 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Analysts See 25% Gains Ahead For The Holdings of FDM
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
InvestorNewsBreaks – Benzinga Launches Global Small Cap Conference Series; First Event Slated for December
From InvestorBrandNetwork
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Participate in Life Sciences Summit Panel
From InvestorBrandNetwork
Genprex to Participate in Panel at Life Sciences Summit on November 17
Genprex's Thomas Gallagher will participate as a panelist at the NYC-based Life Sciences Summit 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Expands Scientific Advisory Board with Strategic Appointment
From InvestorBrandNetwork
Genprex Strengthens Scientific Advisory Board with Appointment of Lead Researcher of University of Pittsburgh, George K. Gittes, MD
George Gittes, MD Joins Genprex's Scientific Advisory Board 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Launch of New Branding for Upcoming Combination Clinical Trials
From InvestorBrandNetwork
Genprex Unveils New Branding for Upcoming Combination Clinical Trials in Non-Small Cell Lung Cancer
Genprex announces new clinical trial branding for upcoming trials in non-small cell lung cancer 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Conditional FDA Acceptance of Proprietary Name for Lead Drug Candidate
From InvestorBrandNetwork
Genprex Receives Conditional FDA Acceptance of Proprietary Name REQORSA™ for Lead Drug Candidate for Treatment of Non-Small Cell Lung Cancer
Genprex receives conditional FDA acceptance of proprietary name Reqorsa(TM) for lead drug candidate 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Appoints Eric Chapdelaine to Senior Manufacturing Team
From InvestorBrandNetwork
Genprex Promotes Eric Chapdelaine to Vice President of Manufacturing
Genprex appoints Eric Chapdelaine to VP of Manufacturing 
From Business Wire News Releases
First Week of June 2021 Options Trading For Genprex (GNPX)
Investors in Genprex Inc (GNPX) saw new options become available this week, for the June 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time... 
Tags Stocks
From Market News Video
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO Scheduled to Present at LD Micro Event
From InvestorBrandNetwork
Genprex to Present at Zooming with LD Micro on October 14, 2020
Genprex will present at the Zooming with LD Micro virtual event 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) to Present at Cell and Gene Therapy Sector’s Foremost Annual Conference
From InvestorBrandNetwork
Genprex to Present at the Alliance for Regenerative Medicine’s Virtual Cell and Gene Meeting on the Mesa
Genprex will present at the Cell and Gene Meeting on the Mesa 
From Business Wire News Releases
BioMedNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Appoints Seasoned Biotech Executive to Advance Expanding IP Estate
From InvestorBrandNetwork
Genprex Names Seasoned IP Executive, Thomas C. Gallagher, as Senior Vice President of Intellectual Property and Licensing
Genprex hires Senior Vice President of IP and Licensing 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Appoints New VP to Oversee Regulatory Affairs
From InvestorBrandNetwork
Genprex Appoints William E. Gannon, Jr., MD, MBA, as Vice President of Regulatory Affairs
Genprex appoints new Vice President of Regulatory Affairs 
From Business Wire News Releases
BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Invited to Present at Prestigious LD 500 Virtual Investor Conference
From InvestorBrandNetwork
Genprex to Present at The LD 500 Virtual Conference
Genprex's Chairman and CEO will present on September 1, 2020 at the LD 500 Virtual Conference 
From Business Wire News Releases
81 Biggest Movers From Friday
Gainers CureVac N.V. (NASDAQ: CVAC) shares jumped 249.4% to close at $55.90 on Friday after the company priced its IPO at $16 per ... 
Tags VRNA CODX SGBX
From Benzinga
4 Penny Stocks To Buy Right Now According To Analysts
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
BioMedNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) CEO Again Featured on ‘Big Biz Show,’ to Present at Proactive’s One2One Virtual Investor Forum
From InvestorBrandNetwork
Genprex to Present at Proactive’s One2One Virtual Investor Forum on August 4, 2020
Genprex's CEO will Present at the Proactive Investor Forum on August 4 at 1:40 p.m. ET 
From Business Wire News Releases
Genprex CEO Participates in a Second-Round Live Interview on the “Big Biz Show”
Genprex appears live on the Big Biz Show for a second time 
From Business Wire News Releases
68 Biggest Movers From Yesterday
Gainers Mexco Energy Corporation (NYSE: MXC) shares climbed 121.9% to close at $8.10 on Wednesday after jumping over 18% on ... 
Tags LIFE ZOM INDO
From Benzinga
Orphan Drug Development to Target Increasing Incidence of Liver Cancer
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.